FUS (also called TLS), EWSR1 and TAF15 (also called TAF2N) are related genes involved in tumor type-specific fusion oncogenes in human malignancies. The FUS-DDIT3 fusion oncogene results from a t(12;16)(q13;p11) chromosome translocation and has a causative role in the initiation of myxoid/round cell liposarcomas (MLS/ RCLS). The FUS-DDIT3 protein induces increased expression of the CAAT/enhancer-binding protein (C/EBP) and nuclear factor-jB (NF-jB)-controlled gene IL8, and the N-terminal FUS part is required for this activation. Chromatin immunoprecipitation analysis showed that FUS-DDIT3 binds the IL8 promoter. Expression studies of the IL8 promoter harboring a C/EBP-NF-jB composite site pinpointed the importance of NF-jB for IL8 expression in FUS-DDIT3-expressing cells. We therefore probed for possible interaction of FUS-DDIT3 with members of the NF-jB family. The nuclear factor NFKBIZ colocalizes with FUS-DDIT3 in nuclear structures, and immunoprecipitation experiments showed that FUS-DDIT3 binds the C-terminal of NFKBIZ. We also report that additional NF-jB-controlled genes are upregulated at the mRNA level in FUS-DDIT3-expressing cell lines and they can be induced by NFKBIZ. Taken together, the results indicate that FUS-DDIT3 deregulates some NF-jB-controlled genes through interactions with NFKBIZ. Similar mechanisms may be a part of the transformation process in other tumor types carrying FUS, EWSR1 and TAF15 containing fusion oncogenes.
Introduction
FUS, EWSR1 and TAF15 are three closely related genes encoding RNA-binding proteins with N-terminal parts sharing stretches of degenerated SYGQQS repeats Morohoshi et al., 1998; Law et al., 2006) . All three genes form fusion oncogenes, generated by chromosome translocations in a large group of human sarcomas and leukemias (Perez-Losada et al., 2000b; Kovar, 2005) . The fusion proteins consist of N-terminal parts of FUS, EWS or TAF15, which are juxtaposed to the DNA-binding parts of various transcription factors, and the chimeric proteins have been shown to act as abnormal transcription factors (Ohno et al., 1993; Sanchez Garcia and Rabbitts, 1994; Zinszner et al., 1994) . In some tumor types, FUS, EWSR1 and TAF15 replace each other as 5 0 fusion partners showing that the N-terminal parts of their protein products share features and functions important for cell transformation and tumor development in these groups of sarcomas and leukemias.
In the present investigation, we focused on myxoid/ round cell liposarcoma (MLS/RCLS). More than 90% of these tumors carry a t(12;16)(q13;p11) chromosome translocation that results in a fusion between FUS and the transcription factor encoding DDIT3 (also called CHOP and GADD153) (Crozat et al., 1993; Rabbitts et al., 1993) . A minority of MLS/RCLS tumors carry a variant fusion gene in which FUS is replaced by EWSR1 . DDIT3 encodes a DNAbinding transcription factor of basic leucine zipper type (CAAT/enhancer-binding protein (C/EBP) family) that binds to DNA as a heterodimer with other C/EBP transcription factors. DDIT3 cannot form homodimers, but C/EBPb, which is natively expressed in the here investigated cells, is considered as a major dimerization partner to DDIT3 and the dimer-forming function is maintained in the FUS-DDIT3 fusion protein (Crozat et al., 1993) . DDIT3 and FUS-DDIT3 may therefore interfere with C/EBPb and its binding to transcription regulatory C/EBP sites.
The causative role of the FUS-DDIT3 fusion gene in the initiation of MLS/RCLS, and its role for the MLSspecific tumor morphology has been demonstrated in transgenic mice and xenografts, and more recently in FUS-DDIT3 carrying mesenchymal stem cells (PerezLosada et al., 2000b; Engstro¨m et al., 2006; Riggi et al., 2006) . The importance of the FUS N-terminal part for oncogenic activity of FUS-DDIT3 was further confirmed by NIH-3T3-based transformation assays (Zinszner et al., 1994) and in transgenic mice (Perez-Losada et al., 2000b) .
We have recently shown that the C/EBP and nuclear factor-kB (NF-kB)-controlled gene IL8 is upregulated in FUS-DDIT3-expressing cell lines, whereas expression of the normal DDIT3 inhibits IL8 transcription (Go¨rans-son et al., 2005) . These observations provided an opportunity to investigate the molecular mechanism behind aberrant gene regulation caused by the FUS-DDIT3 fusion protein.
We here report that interaction with an NF-kBbinding site in the IL8 promoter is crucial for the divergent regulation by DDIT3 and FUS-DDIT3. Our results provide an important insight in the molecular mechanism behind the abnormal transcription factor activity of FUS-DDIT3.
Results
NF-kB is a major factor controlling IL8 transcription in FUS-DDIT3-expressing cells DDIT3 and FUS-DDIT3 give opposite effects on the IL8 transcription in HT1080 cells (Go¨ransson et al., 2005) . To study the mechanism behind this difference, we expressed luciferase reporter constructs containing the C/EBP-NF-kB composite site of the IL8 promoter, or mutant forms of this construct in genetically modified HT1080 cells (Figure 1) .
Deletion of the C/EBP site resulted in reduced IL8 promoter activity in HT1080 showing that transcription from the IL8 promoter depends on the C/EBP site in these cells (Figure 1 ). Similar results were obtained for DDIT3-expressing HT1080 cells in which the activity was strongly reduced. In contrast, FUS-DDIT3-expressing cells were not dependent on the C/EBP-binding site for IL8 promoter activity.
Mutation of the NF-kB site led to a significantly increased promoter activity in the HT1080 control cells. In DDIT3-expressing cells, this increase was more than 14-fold. These results indicate that the NF-kB site functions as a negative regulator of the IL8 promoter in control cells and DDIT3-expressing cells. In contrast, the NF-kB site functions as a strong activator in FUS-DDIT3-expressing cells because mutation of the NF-kB site drastically decreased IL8 promoter activity in these cells. Thus, the fusion of FUS N-terminal parts to DDIT3 results in a switch from a suppressive to a stimulatory effect that is dependent on the NF-kB site.
FUS-DDIT3 binds to the IL8 immediate promoter region
The immediate promoter region of IL8 contains a wellcharacterized C/EBP-NF-kB composite site (Libermann and Baltimore, 1990; Mukaida et al., 1990; Matsusaka et al., 1993) . The observed effects of FUS-DDIT3 and DDIT3 on IL8 expression could be explained by direct binding to this composite site. Chromatin immunoprecipitation (ChIP) experiments with anti-DDIT3 and anti-FUS serum samples on MLS 402-91 cells verified that FUS-DDIT3 bound to the IL8 promoter (Figure 2 ).
FUS-DDIT3 and NFKBIZ colocalize in nuclear structures
We have reported earlier that FUS-DDIT3 localizes to specific nuclear structures Thelin-Ja¨rnum et al., 2002) . We used this feature to search for interactions of FUS-DDIT3 with members of the NF-kB/Rel family in FUS-DDIT3-GFP transfected HT1080 cells. Transfected cells were stained with Cy3-labeled antisera directed against NF-kB1 (p50), NF-kB2 (p52), RELA (p65), RELB and REL, and the cellular distribution of the red and green fluorescence was studied. We found no evident colocalization between the FUS-DDIT3 protein and these NF-kB/Rel family members (data not shown). No useful antibodies were available for the NFKBIZ. However, the nuclear pattern of green fluorescent protein (GFP)-tagged NFKBIZ (Kitamura et al., 2000) closely resembled the localization pattern of FUS-DDIT3-GFP (ThelinJa¨rnum et al., 2002) , prompting us to probe for a colocalization between these proteins. Confocal laserscanning microscopy of HT1080 cells coexpressing FUS-DDIT3 deregulates NF-jB target genes M Göransson et al GFP-tagged NFKBIZ and DsRed1-tagged FUS-DDIT3 revealed that these factors colocalize in nuclear structures ( Figure 3a) . Next, we constructed an N-terminally truncated version of NFKBIZ lacking the nuclear localization signal and tagged the C-terminal with DsRed1. When this construct was expressed alone, the protein localized to the cytoplasm (Figure 3b, I ). In contrast, when coexpressed with FUS-DDIT3-GFP, this mutant localized to the nuclear structures, suggesting that FUS-DDIT3 binds and translocates the C-terminal NFKBIZ to the nucleus (Figure 3b, III) . Furthermore, if strongly expressed, both the FUS-DDIT3-DLZ-GFP construct lacking the leucine zipper dimerizing domain and the wild-type DDIT3 construct were able to translocate NFKBIZ-C-term-DsRed1 to the nucleus (Figure 3b, IV) . This effect was weaker compared with the full-length fusion protein. Similarly, the full-length FUS protein and the N-terminal part of FUS, involved in the FUS-DDIT3 fusion, were found only partially associated with the NFKBIZ mutant protein (Figure 3b , V and VI).
Physical interaction between NFKBIZ and FUS-DDIT3
To confirm a binding between NFKBIZ and FUS-DDIT3, we attempted to precipitate the two proteins together using anti-GFP serum. The C-terminal NFKBIZ-GFP and GFP control vectors were coexpressed with FUS-DDIT3-DsRed1. GFP-tagged proteins were immunoprecipitated, and the co-precipitation of FUS-DDIT3-DsRed1 was analysed. A band of approximately 80 kDa corresponding to FUS-DDIT3-DsRed1 was detected in the immunoprecipitated fraction of C-terminal NFKBIZ-GFP. Coprecipitation of FUS-DDIT3-DsRed1 could not be observed by the GFP control alone (Figure 4 ). These results suggest that NFKBIZ binds directly to FUS-DDIT3 or associates indirectly with FUS-DDIT3 in a larger complex through its C-terminal domain.
The NF-kB-controlled genes MMP1 and LCN2 are upregulated in FUS-DDIT3-expressing cell lines MMP1 and LCN2, both genes involved in extracellular matrix remodeling, were found to be upregulated in FUS-DDIT3-GFP cells, whereas DDIT3 had very little effect (Go¨ransson et al., 2005) . The expression patterns were confirmed here by real-time PCR (Table 1 ). In addition, three investigated myxoid liposarcoma cell lines expressed LCN2 and MMP1 (data not shown).
IL8, IL6 and LCN2 are transcriptional targets of NFKBIZ In addition to IL8, MMP1 has also been shown to be regulated by the NF-kB system, and both IL6 and LCN2 have been reported to be downstream targets of NFKBIZ (Vincenti et al., 1998; Motoyama et al., 2005; Oikawa et al., 2006) . To test whether these genes were transcriptionally controlled by NFKBIZ in our system, we used a tamoxifen-regulated vector system (Littlewood et al., 1995) . Human HT1080 cells were transiently transfected by MOR-GFP or NFKBIZ-MOR-GFP construct for 24 h. The transfection efficiency was approximated to 100% for the MOR-GFP construct and to 30% for the NFKBIZ-MOR-GFP construct by counting GFP-positive cells and by western blot analysis ( Figure 5b ). The expression levels of IL8, IL6, MMP1 and LCN2 were measured by real-time PCR 4 h after the addition of tamoxifen to the cell culture. The results showed that mRNA levels of IL8, IL6 and LCN2 were significantly raised in response to nuclear expression of NFKBIZ ( Figure 5a ). The MMP1 expression was not significantly altered. These findings confirm previous reports that IL6 and LCN2 are downstream targets of NFKBIZ and further suggest that IL8 but not MMP1 is a transcriptional target of the NFKBIZ protein. 
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FUS-DDIT3-expressing cells show resistance to DDIT3-mediated downregulation of target genes
To further investigate the effects of FUS-DDIT3 on the regulation of IL8, IL6 and LCN2, their expression in response to overexpression of mutated variants of FUS-DDIT3 and NFKBIZ in wild-type HT1080 cells and in FUS-DDIT3-expressing HT1080 cells ( Figure 6 ) was studied using quantitative PCR. The results showed that although target gene expression in wild-type HT1080 cells were altered by most constructs, such effects were smaller or absent in FUS-DDIT3-expressing cells. Interestingly, DDIT3 (and FUS-DDIT3) with a deleted leucine zipper dimerization region also induced a Physical interaction between C-terminal NFKBIZ and FUS-DDIT3 revealed by co-immunoprecipitation. HT1080 cells were co-transfected with FUS-DDIT3-DsRed1 and either NFKBIZ-cterm-GFP or empty green fluorescent protein (GFP) vector. Immunoprecipitation was performed using an antibody directed against GFP. Input represents the relative amount of tagged protein present in the cell lysate. IP shows the amount of GFP-tagged constructs bound to Protein A agarose. Co-IP shows the amount of FUS-DDIT3 that was co-precipitated together with the NFKBIZ-Cterm-GFP construct or the empty GFP vector. IB, protein detected by western blot. Values represent fold change compared with the original HT1080 cell line as the mean of three independent biological replicates ± s.e.m.
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decrease in IL8, IL6 and LCN2 gene expressions. Transient transfection of the N-terminal parts of NFKBIZ showed low transfection efficiency and no detectable changes in target gene expression (data not shown). The transfection efficiency was judged by fluorescence microscopy to around 95% for all constructs shown. The large variation in LCN2 expression depended on differences between the biological replicates.
Discussion
The contribution of FUS, EWSR1 and TAF15 to the oncogenic activity of fusion oncogenes is well documented (Kovar et al., 1994; Zinszner et al., 1994 Zinszner et al., , 1997 Perez-Losada et al., 2000a) . The three genes may replace each other as fusion partners with specific transcription factors, indicating that the N-terminal parts of the three proteins share important functions. In the present investigation, we focused on the FUS-DDIT3 fusion oncogene and the differential effects of DDIT3 and FUS-DDIT3 on IL8 transcription.
DDIT3 downregulates IL8, whereas the expression of FUS-DDIT3 results in an upregulation of IL8 in genetically modified HT1080 fibrosarcoma cells (Go¨r-ansson et al., 2005) . Here, we show that the C/EBP site in the composite C/EBP-NF-kB site of the promoter is important for IL8 transcription in control HT1080 cells, as mutation of the C/EBP site resulted in a strongly 
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M Göransson et al reduced transcriptional activity (Figure 1 ). This suggests that the C/EBP site binds a factor, probably the natively expressed C/EBPb, which promotes transcription. On the contrary, the NF-kB site is important for negative regulation of IL8 because mutation of this site leads to an increased transcription. Thus, in wild-type HT1080 cells, the NF-kB site probably binds a protein that suppresses IL8 transcription. Introduction of constitutively expressed GFP-tagged DDIT3 caused a decreased IL8 transcription. According to the current models of DDIT3 action (Ron and Habener, 1992) , DDIT3 forms a dimer with C/EBPb and changes the binding properties of this protein to DNA or to other promoter-interacting proteins. However, in contrast to this conventional model of IL8 regulation and DDIT3-C/EBP activity, our experiments showed that a deletion mutated DDIT3 lacking the leucine zipper dimerization domain caused downregulation of IL8 transcription in wild-type HT1080 cells. Thus, this effect could not be a result of DDIT3-forming dimers with C/EBP proteins. Instead, our results suggest that part of DDIT3's inhibitory effect may be mediated through interactions with a factor binding to the NF-kB site as mutation of the NF-kB site strongly counteracted the inhibitory effects of DDIT3 on IL8 transcription.
Contrary to DDIT3, FUS-DDIT3 caused an increased IL8 transcription and this was maintained in the absence of the C/EBP site. The C/EBP site is therefore not needed for FUS-DDIT3-induced IL8 transcription. Instead, FUS-DDIT3 depends on the NFkB site to stimulate transcription. Data from the ChIP experiment showed that FUS-DDIT3 indeed binds to the IL8 promoter. This binding could be indirect through a complex with an NF-kB site-binding protein.
Whether FUS-DDIT3 binds and blocks the hypothetical suppressor protein at this site or recruits a new factor that replaces the suppressor remains unknown.
Systematic studies of interactions between FUS-DDIT3 and NF-kB factors failed to detect any interactions with NF-kB1 (p50), NF-kB2 (p52), RELA (p65), RELB or REL, but revealed an association between NFKBIZ and FUS-DDIT3. Taken together with the ChIP and reporter assay results, we conclude that FUS-DDIT3 binds to NFKBIZ and that this complex binds the NF-kB site to induce IL8 transcription. Furthermore, overexpression of NFKBIZ in HT1080 cells resulted in elevated IL8 transcription, indicating a role for NFKBIZ. This interpretation is further supported by a recent report showing that NFKBIZ binds and acts on a composite or adjacent C/EBP-NF-kB site almost identical to the site investigated in this study (Matsuo et al., 2007) .
FUS has been reported earlier to interact with the RelA/p65 component of the NF-kB complex (Uranishi et al., 2001 ). However, this interaction is mainly mediated through the C-terminal of FUS, which is lost in the FUS-DDIT3 fusion protein. This might explain why we were unable to detect colocalization between FUS-DDIT3 and RelA/p65 in this study. NF-kB1 was recently reported to interact with NFKBIZ and DNA (Trinh et al., 2008 ) but we could not detect NF-kB1 in complex with FUS-DDIT3 and NFKBIZ.
A previous report showed that the N-terminal of NFKBIZ was important for nuclear localization (Yamazaki et al., 2001) . Our results confirmed these findings, as the N-terminally truncated mutant localized to the cytoplasm. However, coexpression with FUS-DDIT3 showed that FUS-DDIT3 can translocate the NFKBIZ C-terminal to the nucleus. Taken together, the FUS-DDIT3-mediated nuclear transport of NFKBIZ, the co-immunoprecipitation and the nuclear co-localization of FUS-DDIT3 and NFKBIZ indicate that the two proteins bind directly or in a common complex.
NFKBIZ promotes transcription (Kitamura et al., 2000; Motoyama et al., 2005) but may also act as an inhibitor of p50 containing NF-kB complexes (Yamazaki et al., 2001; Totzke et al., 2006) . In this study, we report that the MMP1 and LCN2 genes encoding matrix metalloproteinase 1 and lipocalin 2 (a cofactor for MMP9), both involved in extracellular matrix remodeling, are strongly expressed in FUS-DDIT3 carrying cell lines. MMP1 is reported to be regulated by NF-kB through a distal promoter element (Vincenti et al., 1998) and LCN2 has been reported to be transcriptionally controlled by NFKBIZ (Oikawa et al., 2006) . These findings are supported by our experiments with an inducible NFKBIZ expression vector showing that the mRNA levels of LCN2, but not MMP1, are significantly raised by the nuclear expression of NFKBIZ. The augmented MMP1 transcription in FUS-DDIT3-expressing cells probably results from a different mechanism. Elevated expressions of MMP1 and LCN2 have been reported to be associated with advanced cancers, metastasis and invasiveness (Nakopoulou et al., 1999; Bratt, 2000; Brinckerhoff et al., 2000) , suggesting a role for these genes also in the development of MLS/RCLS.
Extensive attempts to knock down FUS-DDIT3 and NFKBIZ by RNA interference were made with methods that worked successfully in other cell systems but these failed in FUS-DDIT3-carrying cells. Thus, we could not verify the activating effects FUS-DDIT3 or NFKBIZ on target gene expression through such experiments. Instead, transient overexpression of recombinant DDIT3, deletion mutants of DDIT3 and FUS-DDIT3, ankyrin-repeat containing C-terminal NFKBIZ and the N-terminal of FUS were attempted to test the roles of FUS-DDIT3 and NFKBIZ in target gene transcription. These recombinant proteins could potentially act as dominant negatives, competing out binding between FUS-DDIT3 and NFKBIZ. Our results show that the FUS-DDIT3/NFKBIZ target genes IL8, IL6 and LCN2 are more resistant to downregulation by the mutated recombinant proteins in FUS-DDIT3-carrying cells and further support the hypothesis that the fusion oncoprotein imposes a strong transcription regulatory activity on the target genes ( Figure 6) . Part of the mechanism behind this effect may be a tight binding of FUS-DDIT3 to NFKBIZ and the NF-kB site of target gene promoters. The results from the N-terminal FUS and C-terminal NFKBIZ were, however, inconclusive with inhibitory effects only in some conditions. These results FUS-DDIT3 deregulates NF-jB target genes M Göransson et al may depend on the observed low nuclear concentrations of the recombinant proteins, both lacking a nuclear localization sequence.
Involvement of the NF-kB signal transduction and transcription regulatory system has been reported in many human cancers (Sun and Xiao, 2003) . Deregulation of normal NF-kB functions by the FUS-DDIT3 fusion oncoprotein may affect vital functions of the normal cell and contribute to the development of MLS/ RCLS. Growth-regulating genes, such as CCND1, PTX3, JUNB and CCNE, are aberrantly or strongly expressed in FUS-DDIT3-expressing cells (Olofsson et al., 2004; Schwarzbach et al., 2004) , and these genes have been shown to be regulated by NF-kB factors (Biegel et al., 1993; Diffin et al., 1994; Basile et al., 1997; Hinz et al., 1999) . Interaction between FUS-DDIT3 and NFKBIZ may thus lead to transcriptional deregulation of these and many other NF-kB-controlled target genes.
In conclusion, this study shows that the differential effect of normal DDIT3 and oncogenic FUS-DDIT3 on IL8 transcription is linked to interactions with the NF-kB site of the promoter. Binding of FUS-DDIT3 to NFKBIZ may be an important part of the FUS-DDIT3 oncogenic activity and could contribute to the development of this tumor type through the deregulation of additional NF-kB-controlled genes. Similar mechanisms may be involved in other tumor types carrying FUS, EWSR1 and TAF15-associated fusion oncogenes.
Materials and methods

GFP and DsRed1 vector constructs
The full-length coding regions of DDIT3, FUS-DDIT3 cDNA type II (Panagopoulos et al., 1994) and NFKBIZ transcript variant 1 were cloned into the pEGFP-N1 and/or pDsRed1-N1 vectors (Clontech Laboratories, Mountain View, CA, USA) in frame with the GFP or DsRed1 sequence. Similarly, partial cDNAs encoding the C-terminal (amino acids 357-718) part of NFKBIZ, the N-terminal part of FUS involved in the FUS-DDIT3 fusion (FUSA) and DDIT3-DLZ/FUS-DDIT3-DLZ lacking the 38 C-terminal amino acids containing a leucine zipper domain were cloned into the pEGFP-N1 and/or pDsRed1-N1 vectors. MOR-GFP and NFKBIZ-MOR-GFP vectors were constructed by an in-frame ligation of the MOR-LBD construct immediately upstream of the gene encoding GFP. All constructs were confirmed by sequencing.
The mouse estrogen receptor ligand-binding domain (MOR-LBD) construct was made by mutating the wild-type mouse estrogen receptor (a kind gift from Dr M Parker). The ligandbinding domain (DNA encoding amino acids 290-599) of the receptor was cloned using the primer set: MORLBD BamHI-U (5 0 -TATGGATCCAGGAGACATGAGGGCTGCCAACCT TTG-3 0 ) and MORLBD BamHI-L (5 0 -TATGGATCCATCGT GTTGGGGAAGCCCTCT-3 0 ). The G525R point mutation was introduced by PCR mutagenesis and amplification of circular DNA in vitro (Chen and Ruffner, 1998) using the primer set (5 0 -3 0 ): MORLBD mut-U (GGCACATGAGTAA CAAACGCATGG) and MORLBD mut-L (ATGTTGTAGA GATGCTCCATGCGTTTGTT). The MOR-LBD G525R mutant is unable to bind estrogen, yet it retains affinity for a synthetic ligand, 4-hydroxy-tamoxifen. For nuclear translocation of mutant MOR-LBD-fused constructs, 4-hydroxytamoxifen was added to the medium at a final concentration of 100 nM (Littlewood et al., 1995) .
Cell lines
The MLS cell line MLS 402-91 (Å man et al., 1992; ThelinJa¨rnum et al., 1999) and human fibrosarcoma cell lines HT1080, HT1080 DDIT3-GFP and HT1080 FUS-DDIT3-GFP (Engstro¨m et al., 2006) were kept frozen in liquid nitrogen or cultured at 37 1C and 5% CO 2 in RPMI 1640 medium with HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) buffer supplemented with 2 mM L-glutamine, 50 U/ml penicillin, 50 mg/ml streptomycin and 8% fetal calf serum (Invitrogen, Carlsbad, CA, USA). G418 (200 mg/ml, Invitrogen) was constantly added to cell lines HT1080 FUSA-GFP, HT1080 DDIT3-GFP and HT1080 FUS-DDIT3-GFP to ensure stable expression of GFP constructs in the cell population.
Luciferase reporter assay A PCR fragment corresponding to nucleotides À109 to À1 of the IL8 promoter was generated using the IL8PromU-XhoI (5 0 -ATACTCGAGGGGATGGGCCATCA-3 0 ) and IL8-PromL-XhoI (5 0 -ATACTCGAGTGCTCCGGTGGCTT-3 0 ) primer pair, and subsequently cloned into the pGL2 Enhancer vector (Promega Corporation, Madison, WI, USA). Mutants were generated by PCR using IL8PromDCEBP-U-XhoI (5 0 -ATACTCGAGCGTGGAATTTCCTC-3 0 ) or IL8PromDNF-kB-U-XhoI (5 0 -ATACTCGAGTTGCAAATCGTGGTTTTT CC-3 0 ) together with IL8PromL-XhoI. In the C/EBP mutant, the CAGTTGCAAT sequence was deleted from the C/EBP-NF-kB composite site (5 0 -CAGTTGCAATCGTGGAATT TCC-3 0 ), and in the NF-kB mutant, the GGAATTCC element was changed to GGTTTTTCC. All constructs were confirmed by sequencing. The pCI b-gal expression vector was a kind gift from Dr Y Arvidsson. Cells were co-transfected using 1 mg pGL2 enhancer construct and 0.4 mg pCI b-gal vector in 12-well plates and harvested in 100 ml reporter lysis buffer (Promega) 48 h after transfection. Luciferase activity was detected using Promega's Luciferase Assay System and normalized against b-galactosidase activity in each sample. Each experiment was conducted twice in biological triplicates.
Colocalization studies
Colocalization studies were performed (as described earlier Go¨ransson et al., 2002) in flaskettes (Nalgene Nunc Thermo Fisher Scientific, Rochester, NY, USA) using 1 mg of each plasmid construct for transfection. HT1080 cells were washed twice in phosphate-buffered saline (PBS) of 0.01 M, pH 7.2 (PBS) and fixed in 4% formaldehyde in PBS 24 h after transfection. For immunofluorescence studies, the following antisera were used: NF-kB1 (06-886; Millipore, Billerica, MA, USA), NF-kB2 (C-5), Rel A (F-6), RelB (C-19), c-Rel (N-466) and bcl3 (C-14) (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Cells were mounted in Prolong Gold with DAPI (4 0 ,6-diamidino-2-phenylindole; Invitrogen) and let to cure overnight. The intracellular localization of fluorescently tagged proteins was recorded using a Zeiss LSM 510 META system with LSM-5 software supplied by the manufacturer. Settings for confocal microscopy were as follows: DAPI, 405 nm excitation and emission BP 420-480 filter; GFP, 488 nm excitation and emission BP 505-530 filter; and DsRed1, 561 nm excitation and emission META detector 572-625 nm.
Immunoprecipitation and western blot
ChIP studies were performed as described elsewhere (Caretti et al., 2003) with antibodies FUS (H76), and DDIT3 (GADD153 R20) from Santa Cruz Biotechnology. Satellite FUS-DDIT3 deregulates NF-jB target genes M Göransson et al sequences repeated at multiple positions in the genome were used as a control for unspecific precipitation and as a loading control. The PCR primers used for detection of the IL8 proximal promoter sequences were (5 0 -3 0 ): forward: AGGTTTGCCCTGAGGGGATG and reverse: GCTTGTG TGCTCTGCTGTCTC. Control satellite sequences were amplified using forward CAATTATCCCTTCGGGGAATCGG and reverse GGCGACCAATAGCCAAAAAAGTGAG primers.
Immunoprecipitation experiments for FUS-DDIT3 and NFKBIZ were carried out on human fibrosarcoma HT1080 cells transiently co-transfected with NFKBIZ-GFP and FUS-DDIT3-DsRed1. The cells were harvested 24 h after transfection and lysed in lysis buffer (50 mM Tris-HCl pH 7.4, 1% NP-40, 50 mM NaCl, 0.1 mM EDTA, 10% protease inhibitor cocktail (no. 1836153; Roche, Basel, Switzerland). The lysates were incubated overnight with 4 mg anti-GFP peptide antibody (no. 8367-2; Clontech Laboratories) and precipitated using 50 ml protein A agarose beads (Millipore). The precipitates were washed three times in lysis buffer and eluated in LDS western sample buffer (Invitrogen) containing 10% protease inhibitor cocktail. Input and immunoprecipitated material were separated on 4-12% SDS-polyacrylamide gels (Invitrogen), blotted onto Immobilon-P PDVF (polyvinylidene fluoride) membranes (Millipore) and detected using antibodies directed against GFP (8367-2; Clontech Laboratories) or DDIT3 (GADD153 R20; Santa Cruz Biotechnology), followed by alkaline phosphatase-conjugated secondary antibodies (Dako, Glostrup, Denmark) and CDP-Star (Tropix, Bedford, MA, USA) as substrate. The chemiluminescent signal was detected using electrochemiluminescence film (Kodak, Rochester, NY, USA). Similarly, the GFP antibody was used to detect the MOR-GFP construct, and rabbit antisera raised against the N-terminal part of NFKBIZ isoform A was used to detect the NFKBIZ-MOR-GFP construct in transiently transfected HT1080 cells.
Real-time PCR analysis
Cells were washed twice in cold PBS, and total RNA was isolated using the QIAshredder and RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA was generated from 5 mg total RNA using oligo dT primers and Superscript III reverse transcriptase (Invitrogen) or using a QuantiTect Reverse transcription kit (Qiagen). Real-time PCR was measured in the LightCycler (Roche) as described earlier (Sta˚hlberg et al., 2004) or alternatively using a 7500 Fast real-time PCR system (Applied Biosystems, Foster City, CA, USA) with SYBR Green detection (Qiagen). Formation of expected PCR products were confirmed by agarose gel electrophoresis and melt curve analysis. Gene expression data were normalized against ACTB and GAPDH by geometric averaging (Vandesompele et al., 2002) . The expressions of ACTB, GAPDH, IL8, IL6, MMP1 and LCN2 were monitored using the following primer pairs (5 0 -3 0 ): ACTBU (TCATGAAGTGTGTGACGTT GACATCCGT), ACTBL (CCTAGAAGCAATTTGCGGT GCACGATG); GAPDHU (GTGAAGGTCGGAGTCAAC G), GAPDHL (GGTGAAGACGCCAGTGGACTC); IL8U (TACTCCAAACCTTTCCACCCC), IL8L (CCTTGGCCTC AATTTTGCTAT; IL8_133F (CAGCCTTCCTGATTTCT GC), IL8_375R (ACTTCTCCACAACCCTCTGC); IL6U (CAGCCCTGAGAAAGGAGACAT), IL6L (AATCTGA GGTGCCCATGCTAC); IL6_187F (CACACAGACAGCCA CTCACC), IL6_364R (CATCCATCTTTTTCAGCCATC); MMP1U (TACAACTTACATCGTGTTGCG), MMP1L (G GTTTTTCCAGTGTTTTCCTC); LCN2U (GGGAAGTG GTATGTGGTAGGC), LCN2L (GATTGGGACAGGGA AGACGAT). ACTB and GAPDH expressions were also measured using primers contained in the Human Endogenous Control Gene Panel supplied by TATAA Biocenter, Gothenburg, Sweden. All experiments were performed in at least three independent biological replicates.
Statistical methods
Independent samples t-test (using the SPSS software (SPSS, Chicago, IL, USA)) was used to compare luciferase activity between different IL8 promoters in luciferase reporter assays, as well as differences in IL8, IL6, MMP1 and LCN2 expressions were quantified by real-time PCR. P-values of less than 0.05 were considered significant. All statistical tests were two-tailed.
